Firm begins study of sepsis detection device

09/12/2013 | MassDevice.com (Boston)

T2 Biosystems has kicked off a clinical study of its T2Candida test, which is used to detect a fungus often linked to hospital-acquired infections that can trigger sepsis. Data from the trial will be used to support the company's regulatory application for the assay, which takes just about three hours to spot a single colony-forming unit of the Candida fungus in a 1-milliliter blood sample.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Counsel, Regulatory (FDA)
CareFusion
San Diego , CA
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations